Raban Jeger researcher
Jeger, Raban Victor 1970-
VIAF ID: 193119359 (Personal)
Permalink: http://viaf.org/viaf/193119359
Preferred Forms
-
- 100 1 _ ‡a Jeger, Raban Victor ‡d 1970-
- 100 1 _ ‡a Jeger, Raban Victor ‡d 1970-
- 100 0 _ ‡a Raban Jeger ‡c researcher
4xx's: Alternate Name Forms (3)
5xx's: Related Names (1)
Works
Title | Sources |
---|---|
By a Hair's Breadth. | |
Cardiovascular outcomes in high risk patients with osteoarthritis treated with ibuprofen, naproxen or lumiracoxib | |
Comparison of procedural and clinical outcomes with Evolut R versus Medtronic CoreValve: a Swiss TAVI registry analysis | |
Competing risks of major bleeding and thrombotic events with prasugrel-based dual antiplatelet therapy after stent implantation - An observational analysis from BASKET-PROVE II | |
Direct Comparison of Cardiac Troponin T and I Using a Uniform and a Sex-Specific Approach in the Detection of Functionally Relevant Coronary Artery Disease | |
Do ultrathin strut bare-metal stents with passive coating improve efficacy in large coronary arteries? Insights from the randomized, multicenter BASKET-PROVE trials | |
Drug-coated balloons for small coronary artery disease (BASKET-SMALL 2): an open-label randomised non-inferiority trial | |
Drug-coated Balloons for Small Coronary Vessel Interventions: A Literature Review | |
Drug-coated balloons for treatment of coronary artery disease: updated recommendations from a consensus group. | |
Drug-coated balloons in cardiovascular disease: benefits, challenges, and clinical applications | |
Drug-coated balloons: room for development of BASKET-SMALL 2 - Authors' reply | |
Drug-eluting stents and glycoprotein IIb/IIIa inhibitors in vessels at low anatomic risk: a retrospective analysis of previously published data from the Basel Stent Kosten Effektivitäts Trial | |
Early revascularization is beneficial across all ages and a wide spectrum of cardiogenic shock severity: A pooled analysis of trials. | |
Electrophysiology Testing to Stratify Patients With Left Bundle Branch Block After Transcatheter Aortic Valve Implantation | |
Emergency revascularization in patients with cardiogenic shock on admission: a report from the SHOCK trial and registry | |
First-generation paclitaxel- vs. second-generation zotarolimus-eluting stents in small coronary arteries: the BASKET-SMALL : pilot study | |
First-in-man Portico® transcatheter aortic valve-in-valve implantation in a degenerated 19 mm Mitroflow® aortic pericardial heart valve. | |
The hospital results and 1-year outcomes of transcatheter aortic valve-in-valve procedures and transcatheter aortic valve implantations in the native valves: the results from the Swiss-TAVI Registry | |
Impact of aetiology of mitral regurgitation on outcome after Mitraclip: lessons learned from MitraSwiss Registry | |
Impact of Diabetes Mellitus in Women Undergoing Percutaneous Coronary Intervention With Drug-Eluting Stents | |
Impact of percutaneous closure device type on vascular and bleeding complications after TAVR: A post hoc analysis from the BRAVO-3 randomized trial | |
Incidence and Predictors of Cardiomyocyte Injury in Elective Coronary Angiography. | |
Interventional treatment for structural heart disease: who is deciding, and can we afford it? | |
Mens sana in corpore sano revisited | |
The Neurocardiogenic Spectrum in Subarachnoid Hemorrhage: A Case Report and Review of the Literature. | |
New-onset or Pre-existing Atrial Fibrillation in Acute Coronary Syndromes: Two Distinct Phenomena With a Similar Prognosis. | |
Outcome of patients admitted with acute coronary syndrome on palliative treatment: insights from the nationwide AMIS Plus Registry 1997-2014. | |
Percutaneous mitral valve edge-to-edge repair: in-hospital results and 1-year follow-up of 628 patients of the 2011-2012 Pilot European Sentinel Registry. | |
Perioperative major adverse cardiac events in urgent femoral artery repair after coronary stenting are less common than previously reported | |
Predicting Mortality After Transcatheter Aortic Valve Replacement: External Validation of the Transcatheter Valve Therapy Registry Model. | |
Prevalence and determinants of exercise-induced left ventricular dysfunction in patients with coronary artery disease | |
Prognostic value of "routine" cardiac stress imaging 5 years after percutaneous coronary intervention: the prospective long-term observational BASKET (Basel Stent Kosteneffektivitäts Trial) LATE IMAGING study. | |
Progression to overt or silent CAD in asymptomatic patients with diabetes mellitus at high coronary risk: main findings of the prospective multicenter BARDOT trial with a pilot randomized treatment substudy. | |
Prolonged dual antiplatelet therapy in renal failure: a challenging trade-off | |
A Randomized Trial of Recombinant Human C1-Esterase-Inhibitor in the Prevention of Contrast-Induced Kidney Injury | |
Safety and efficacy of drug-eluting stents in women: a patient-level pooled analysis of randomised trials | |
Second generation drug-eluting stents versus bare-metal stents for percutaneous coronary intervention of the proximal left anterior descending artery: An analysis of the BASKET-PROVE I and II trials. | |
Sex-based differences in outcomes with bivalirudin or unfractionated heparin for transcatheter aortic valve replacement: Results from the BRAVO-3 randomized trial. | |
Sex-Specific Management in Patients With Acute Myocardial Infarction and Cardiogenic Shock: A Substudy of the CULPRIT-SHOCK Trial | |
Stent thrombosis after coronary stent implantation: a protective effect of high-dose statin therapy? | |
Stents in saphenous vein grafts | |
Supra-annular sizing for transcatheter valve implantation in bicuspid aortic stenosis. | |
Survival After Coronary Revascularization With Paclitaxel-Coated Balloons | |
Thrombin-receptor antagonist vorapaxar in acute coronary syndromes | |
Transcatheter aortic valve replacement in Europe: adoption trends and factors influencing device utilization. | |
Twenty-Year Trends in the Incidence and Outcome of Cardiogenic Shock in AMIS Plus Registry | |
Using High-Sensitivity Cardiac Troponin for the Exclusion of Inducible Myocardial Ischemia in Symptomatic Patients: A Cohort Study | |
Vollständig resorbierbare Stents – eine neue Ära in der Behandlung der koronaren Herzkrankheit? |